BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37345586)

  • 21. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
    Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
    [No Abstract]   [Full Text] [Related]  

  • 22. BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells.
    Jiang ZY; Ma XM; Luan XH; Liuyang ZY; Hong YY; Dai Y; Dong QH; Wang GY
    World J Gastroenterol; 2023 Jun; 29(23):3606-3621. PubMed ID: 37398890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling.
    Zhong B; Cheng B; Huang X; Xiao Q; Niu Z; Chen YF; Yu Q; Wang W; Wu XJ
    Cell Death Dis; 2021 Dec; 13(1):16. PubMed ID: 34930899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts.
    Zhang C; Wang XY; Zhang P; He TC; Han JH; Zhang R; Lin J; Fan J; Lu L; Zhu WW; Jia HL; Zhang JB; Chen JH
    Cell Death Dis; 2022 Jan; 13(1):57. PubMed ID: 35027547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression.
    Lang L; Shull AY; Teng Y
    Curr Cancer Drug Targets; 2019; 19(1):17-25. PubMed ID: 29557750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations.
    Mellor HR
    Liver Int; 2014 Jul; 34(6):e1-9. PubMed ID: 24393342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.
    Li Y; Zhang W; Doughtie A; Cui G; Li X; Pandit H; Yang Y; Li S; Martin R
    Oncotarget; 2016 Aug; 7(32):52329-52339. PubMed ID: 27447573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Sphingomyelin Phosphodiesterase 3 in Liver Regeneration Impedes the Progression of Colorectal Cancer Liver Metastasis Via Exosome-Bound Intercellular Transfer of Ceramides.
    Li Q; Li J; Wang K; Liao L; Li Y; Liang H; Huang C; Gan J; Dong X; Hu Y; Cheng J; Ji H; Liu C; Zeng M; Yu S; Wang B; Qian J; Tang Z; Peng Y; Tang S; Li M; Zhou J; Yan J; Li C
    Cell Mol Gastroenterol Hepatol; 2023; 16(3):385-410. PubMed ID: 37245564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
    Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.
    Gao L; Wang X; Tang Y; Huang S; Hu CA; Teng Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):8. PubMed ID: 28069043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.
    Miura S; Mitsuhashi N; Shimizu H; Kimura F; Yoshidome H; Otsuka M; Kato A; Shida T; Okamura D; Miyazaki M
    BMC Cancer; 2012 Feb; 12():56. PubMed ID: 22309595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response.
    Xia Y; He J; Zhang H; Wang H; Tetz G; Maguire CA; Wang Y; Onuma A; Genkin D; Tetz V; Stepanov A; Terekhov S; Ukrainskaya V; Huang H; Tsung A
    Mol Oncol; 2020 Nov; 14(11):2920-2935. PubMed ID: 32813937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HRG inhibits liver cancer lung metastasis by suppressing neutrophil extracellular trap formation.
    Yin Y; Dai H; Sun X; Xi Z; Zhang J; Pan Y; Huang Y; Ma X; Xia Q; He K
    Clin Transl Med; 2023 Jun; 13(6):e1283. PubMed ID: 37254661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.
    Zhou M; Yang H; Learned RM; Tian H; Ling L
    Nat Commun; 2017 May; 8():15433. PubMed ID: 28508871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma.
    Gao L; Lang L; Zhao X; Shay C; Shull AY; Teng Y
    Oncogene; 2019 Mar; 38(13):2394-2404. PubMed ID: 30518874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal Adenoma.
    Wang D; Zhang J; Li Z; Han J; Gao Y; Chen M; Li Y
    Dig Dis; 2019; 37(3):214-225. PubMed ID: 30517925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.
    Hatlen MA; Schmidt-Kittler O; Sherwin CA; Rozsahegyi E; Rubin N; Sheets MP; Kim JL; Miduturu C; Bifulco N; Brooijmans N; Shi H; Guzi T; Boral A; Lengauer C; Dorsch M; Kim RD; Kang YK; Wolf BB; Hoeflich KP
    Cancer Discov; 2019 Dec; 9(12):1686-1695. PubMed ID: 31575540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal FGF19-GLI2 signaling induces epithelial-to-mesenchymal transition to promote lung squamous cell carcinoma metastasis.
    Zhang Y; Wu T; Wang Y; Chen Z; Chen J; Lu S; Xia W
    Cell Oncol (Dordr); 2023 Apr; 46(2):437-450. PubMed ID: 36598638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
    Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.